CD3+CD4+gp130+ T Cells Are Associated With Worse Disease Activity in Systemic Lupus Erythematosus Patients

The receptors for IL-35, IL-12Rβ2 and gp130, have been implicated in the inflammatory pathophysiology of autoimmune diseases. In this study, we set out to investigate the serum IL-35 levels and the surface levels of IL-12Rβ2 and gp130 in CD3+CD4+, CD3+CD4─ and CD3─CD4─ lymphocyte subpopulations in s...

Full description

Bibliographic Details
Main Authors: Nur Diyana Mohd Shukri, Aziz Farah Izati, Wan Syamimee Wan Ghazali, Che Maraina Che Hussin, Kah Keng Wong
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.675250/full
_version_ 1818622203567013888
author Nur Diyana Mohd Shukri
Nur Diyana Mohd Shukri
Aziz Farah Izati
Aziz Farah Izati
Wan Syamimee Wan Ghazali
Wan Syamimee Wan Ghazali
Che Maraina Che Hussin
Che Maraina Che Hussin
Kah Keng Wong
Kah Keng Wong
author_facet Nur Diyana Mohd Shukri
Nur Diyana Mohd Shukri
Aziz Farah Izati
Aziz Farah Izati
Wan Syamimee Wan Ghazali
Wan Syamimee Wan Ghazali
Che Maraina Che Hussin
Che Maraina Che Hussin
Kah Keng Wong
Kah Keng Wong
author_sort Nur Diyana Mohd Shukri
collection DOAJ
description The receptors for IL-35, IL-12Rβ2 and gp130, have been implicated in the inflammatory pathophysiology of autoimmune diseases. In this study, we set out to investigate the serum IL-35 levels and the surface levels of IL-12Rβ2 and gp130 in CD3+CD4+, CD3+CD4─ and CD3─CD4─ lymphocyte subpopulations in systemic lupus erythematosus (SLE) patients (n=50) versus healthy controls (n=50). The potential T cell subsets associated with gp130 transcript (i.e. IL6ST) expression in CD4+ T cells of SLE patients was also examined in publicly-available gene expression profiling (GEP) datasets. Here, we report that serum IL-35 levels were significantly higher in SLE patients than healthy controls (p=0.038) but it was not associated with SLEDAI-2K scores. The proportions of IL-12Rβ2+ and gp130+ cells in SLE patients did not differ significantly with those of healthy controls in all lymphocyte subpopulations investigated. Essentially, higher SLEDAI-2K scores were positively correlated with increased proportion of gp130+ cells, but not IL-12Rβ2+ cells, on CD3+CD4+ T cells (r=0.425, p=0.002, q=0.016). Gene Set Enrichment Analysis (GSEA) of a GEP dataset of CD4+ T cells isolated from SLE patients (n=8; GSE4588) showed that IL6ST expression was positively associated with genes upregulated in CD4+ T cells vs myeloid or B cells (q<0.001). In an independent GEP dataset of CD4+ T cells isolated from SLE patients (n=9; GSE1057), IL6ST expression was induced upon anti-CD3 stimulation, and that Treg, TCM and CCR7+ T cells gene sets were significantly enriched (q<0.05) by genes highly correlated with IL6ST expression (n=92 genes; r>0.75 with IL6ST expression) upon anti-CD3 stimulation in these SLE patients. In conclusion, gp130 signaling in CD3+CD4+ T cell subsets may contribute to increased disease activity in SLE patients, and it represents a promising therapeutic target for inhibition in the disease.
first_indexed 2024-12-16T18:21:26Z
format Article
id doaj.art-54af646aa71a4175984b8a904f539baa
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-16T18:21:26Z
publishDate 2021-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-54af646aa71a4175984b8a904f539baa2022-12-21T22:21:32ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-06-011210.3389/fimmu.2021.675250675250CD3+CD4+gp130+ T Cells Are Associated With Worse Disease Activity in Systemic Lupus Erythematosus PatientsNur Diyana Mohd Shukri0Nur Diyana Mohd Shukri1Aziz Farah Izati2Aziz Farah Izati3Wan Syamimee Wan Ghazali4Wan Syamimee Wan Ghazali5Che Maraina Che Hussin6Che Maraina Che Hussin7Kah Keng Wong8Kah Keng Wong9Department of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, MalaysiaHospital Universiti Sains Malaysia, Kubang Kerian, MalaysiaDepartment of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, MalaysiaHospital Universiti Sains Malaysia, Kubang Kerian, MalaysiaHospital Universiti Sains Malaysia, Kubang Kerian, MalaysiaDepartment of Internal Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, MalaysiaDepartment of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, MalaysiaHospital Universiti Sains Malaysia, Kubang Kerian, MalaysiaDepartment of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, MalaysiaHospital Universiti Sains Malaysia, Kubang Kerian, MalaysiaThe receptors for IL-35, IL-12Rβ2 and gp130, have been implicated in the inflammatory pathophysiology of autoimmune diseases. In this study, we set out to investigate the serum IL-35 levels and the surface levels of IL-12Rβ2 and gp130 in CD3+CD4+, CD3+CD4─ and CD3─CD4─ lymphocyte subpopulations in systemic lupus erythematosus (SLE) patients (n=50) versus healthy controls (n=50). The potential T cell subsets associated with gp130 transcript (i.e. IL6ST) expression in CD4+ T cells of SLE patients was also examined in publicly-available gene expression profiling (GEP) datasets. Here, we report that serum IL-35 levels were significantly higher in SLE patients than healthy controls (p=0.038) but it was not associated with SLEDAI-2K scores. The proportions of IL-12Rβ2+ and gp130+ cells in SLE patients did not differ significantly with those of healthy controls in all lymphocyte subpopulations investigated. Essentially, higher SLEDAI-2K scores were positively correlated with increased proportion of gp130+ cells, but not IL-12Rβ2+ cells, on CD3+CD4+ T cells (r=0.425, p=0.002, q=0.016). Gene Set Enrichment Analysis (GSEA) of a GEP dataset of CD4+ T cells isolated from SLE patients (n=8; GSE4588) showed that IL6ST expression was positively associated with genes upregulated in CD4+ T cells vs myeloid or B cells (q<0.001). In an independent GEP dataset of CD4+ T cells isolated from SLE patients (n=9; GSE1057), IL6ST expression was induced upon anti-CD3 stimulation, and that Treg, TCM and CCR7+ T cells gene sets were significantly enriched (q<0.05) by genes highly correlated with IL6ST expression (n=92 genes; r>0.75 with IL6ST expression) upon anti-CD3 stimulation in these SLE patients. In conclusion, gp130 signaling in CD3+CD4+ T cell subsets may contribute to increased disease activity in SLE patients, and it represents a promising therapeutic target for inhibition in the disease.https://www.frontiersin.org/articles/10.3389/fimmu.2021.675250/fullsystemic lupus erythematosusgp130IL6STIL-35IL-12Rβ2SLEDAI-2K
spellingShingle Nur Diyana Mohd Shukri
Nur Diyana Mohd Shukri
Aziz Farah Izati
Aziz Farah Izati
Wan Syamimee Wan Ghazali
Wan Syamimee Wan Ghazali
Che Maraina Che Hussin
Che Maraina Che Hussin
Kah Keng Wong
Kah Keng Wong
CD3+CD4+gp130+ T Cells Are Associated With Worse Disease Activity in Systemic Lupus Erythematosus Patients
Frontiers in Immunology
systemic lupus erythematosus
gp130
IL6ST
IL-35
IL-12Rβ2
SLEDAI-2K
title CD3+CD4+gp130+ T Cells Are Associated With Worse Disease Activity in Systemic Lupus Erythematosus Patients
title_full CD3+CD4+gp130+ T Cells Are Associated With Worse Disease Activity in Systemic Lupus Erythematosus Patients
title_fullStr CD3+CD4+gp130+ T Cells Are Associated With Worse Disease Activity in Systemic Lupus Erythematosus Patients
title_full_unstemmed CD3+CD4+gp130+ T Cells Are Associated With Worse Disease Activity in Systemic Lupus Erythematosus Patients
title_short CD3+CD4+gp130+ T Cells Are Associated With Worse Disease Activity in Systemic Lupus Erythematosus Patients
title_sort cd3 cd4 gp130 t cells are associated with worse disease activity in systemic lupus erythematosus patients
topic systemic lupus erythematosus
gp130
IL6ST
IL-35
IL-12Rβ2
SLEDAI-2K
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.675250/full
work_keys_str_mv AT nurdiyanamohdshukri cd3cd4gp130tcellsareassociatedwithworsediseaseactivityinsystemiclupuserythematosuspatients
AT nurdiyanamohdshukri cd3cd4gp130tcellsareassociatedwithworsediseaseactivityinsystemiclupuserythematosuspatients
AT azizfarahizati cd3cd4gp130tcellsareassociatedwithworsediseaseactivityinsystemiclupuserythematosuspatients
AT azizfarahizati cd3cd4gp130tcellsareassociatedwithworsediseaseactivityinsystemiclupuserythematosuspatients
AT wansyamimeewanghazali cd3cd4gp130tcellsareassociatedwithworsediseaseactivityinsystemiclupuserythematosuspatients
AT wansyamimeewanghazali cd3cd4gp130tcellsareassociatedwithworsediseaseactivityinsystemiclupuserythematosuspatients
AT chemarainachehussin cd3cd4gp130tcellsareassociatedwithworsediseaseactivityinsystemiclupuserythematosuspatients
AT chemarainachehussin cd3cd4gp130tcellsareassociatedwithworsediseaseactivityinsystemiclupuserythematosuspatients
AT kahkengwong cd3cd4gp130tcellsareassociatedwithworsediseaseactivityinsystemiclupuserythematosuspatients
AT kahkengwong cd3cd4gp130tcellsareassociatedwithworsediseaseactivityinsystemiclupuserythematosuspatients